id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-304240-rqlfnywm	Bloomgarden, Zachary	Does glycemic control affect outcome of COVID‐19?	2020-10-03		.txt	text/plain	681	41	53	In a whole-population study of a UK data set of >60 million persons, approximately 5% had diabetes, but of 23 698 in-hospital COVID-19-related deaths in this population, 33.2% were of people with diabetes, with mortality rates among persons those with type 1 and type 2 diabetes approximately 5-fold and 10-fold greater than that in the nondiabetic population; with adjustment for age and other risk factors, type 1 and type 2 diabetes were associated with near tripling and doubling of mortality rates, respectively. It is then logical to ask whether the adverse outcome of COVID-19 among persons with diabetes is related to the degree of hyperglycemia and, if so, whether this represents a causal relationship or rather shows that the severity of illness in a given individual with diabetes leads to both higher blood glucose concentration and greater likelihood of mortality. 3 Specific hospitalized patient data sets, however, do not show that prior glycemic control, as reflected in HbA1c, are associated with different likelihood of adverse outcome among persons with diabetes.	./cache/cord-304240-rqlfnywm.txt	./txt/cord-304240-rqlfnywm.txt